165 related articles for article (PubMed ID: 10659480)
21. Effect of shunt surgery on spleen size, portal pressure and oesophageal varices in patients with non-cirrhotic portal hypertension.
Sharma BC; Singh RP; Chawla YK; Narasimhan KL; Rao KL; Mitra SK; Dilawari JB
J Gastroenterol Hepatol; 1997 Aug; 12(8):582-4. PubMed ID: 9304510
[TBL] [Abstract][Full Text] [Related]
22. Mesenterico left portal bypass for variceal bleeding owing to extrahepatic portal hypertension caused by portal vein thrombosis.
Ateş O; Hakgüder G; Olguner M; Seçil M; Karaca I; Akgür FM
J Pediatr Surg; 2006 Jul; 41(7):1259-63. PubMed ID: 16818059
[TBL] [Abstract][Full Text] [Related]
23. Results of endoscopic variceal sclerotherapy: influence of etiology of portal hypertension and hepatic functional status.
Bhargava DK; Dasarathy S; Sundaram KR; Ahuja RK
Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():32-5. PubMed ID: 1884957
[TBL] [Abstract][Full Text] [Related]
24. Management of esophageal varices in children by endoscopic variceal ligation.
Price MR; Sartorelli KH; Karrer FM; Narkewicz MR; Sokol RJ; Lilly JR
J Pediatr Surg; 1996 Aug; 31(8):1056-9. PubMed ID: 8863233
[TBL] [Abstract][Full Text] [Related]
25. Longterm outcome after injection sclerotherapy for oesophageal varices in children with extrahepatic portal hypertension.
Stringer MD; Howard ER
Gut; 1994 Feb; 35(2):257-9. PubMed ID: 8307479
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of endoscopic sclerotherapy on long-term management of oesophageal varices: a comparative study of results in patients with cirrhosis of the liver, non-cirrhotic portal fibrosis (NCPF) and extrahepatic portal venous obstruction (EHO).
Bhargava DK; Dasarathy S; Sundaram KR; Ahuja RK
J Gastroenterol Hepatol; 1991; 6(5):471-5. PubMed ID: 1932668
[TBL] [Abstract][Full Text] [Related]
27. Management of extra hepatic portal venous obstruction (EHPVO): current strategies.
Poddar U; Borkar V
Trop Gastroenterol; 2011; 32(2):94-102. PubMed ID: 21922871
[TBL] [Abstract][Full Text] [Related]
28. Portal hypertension.
Karrer FM
Semin Pediatr Surg; 1992 May; 1(2):134-44. PubMed ID: 1345480
[TBL] [Abstract][Full Text] [Related]
29. Transient Elastography (Fibroscan) in Patients with Non-cirrhotic Portal Fibrosis.
Sharma P; Agarwal R; Dhawan S; Bansal N; Singla V; Kumar A; Arora A
J Clin Exp Hepatol; 2017 Sep; 7(3):230-234. PubMed ID: 28970710
[TBL] [Abstract][Full Text] [Related]
30. Portosystemic shunting for paediatric portal hypertension.
Shun A; Delaney DP; Martin HC; Henry GM; Stephen M
J Pediatr Surg; 1997 Mar; 32(3):489-93. PubMed ID: 9094025
[TBL] [Abstract][Full Text] [Related]
31. Variceal recurrence, rebleeding rates and alterations in clinical and laboratory parameters following post-variceal obliteration using endoscopic sclerotherapy.
Krishnan A; Srinivasan V; Venkataraman J
J Dig Dis; 2012 Nov; 13(11):596-600. PubMed ID: 23107447
[TBL] [Abstract][Full Text] [Related]
32. Presentation and natural history of variceal bleeding in patients with portal hypertension due to extrahepatic portal venous obstruction.
Shah SR; Mathur SK
Indian J Gastroenterol; 2003; 22(6):217-20. PubMed ID: 15030033
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy of emergency endoscopic sclerotherapy for active variceal bleeding due to cirrhosis of the liver, non-cirrhotic portal fibrosis and extrahepatic portal venous obstruction.
Bhargava DK; Dasarathy S; Atmakuri SP; Dwivedi M
J Gastroenterol Hepatol; 1990; 5(4):432-7. PubMed ID: 2129815
[TBL] [Abstract][Full Text] [Related]
34. Frequency and factors influencing portal hypertensive gastropathy and duodenopathy in cirrhotic portal hypertension.
Gupta R; Saraswat VA; Kumar M; Naik SR; Pandey R
J Gastroenterol Hepatol; 1996 Aug; 11(8):728-33. PubMed ID: 8872769
[TBL] [Abstract][Full Text] [Related]
35. Portal hypertension in children: High-risk varices, primary prophylaxis and consequences of bleeding.
Duché M; Ducot B; Ackermann O; Guérin F; Jacquemin E; Bernard O
J Hepatol; 2017 Feb; 66(2):320-327. PubMed ID: 27663417
[TBL] [Abstract][Full Text] [Related]
36. The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study.
Zheng J; Zhang Y; Li P; Zhang S; Li Y; Li L; Ding H
BMC Gastroenterol; 2019 Feb; 19(1):32. PubMed ID: 30782139
[TBL] [Abstract][Full Text] [Related]
37. Predictors of variceal bleed among patients with liver cirrhosis in the era of sclerotherapy.
Varghese J; Cherian JV; Solomon R; Jayanthi V
Singapore Med J; 2008 Mar; 49(3):239-42. PubMed ID: 18363007
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of endoscopic sclerotherapy on long-term management of oesophageal varices due to cirrhosis of liver, non-cirrhotic portal fibrosis and extrahepatic obstruction: comparison of results.
Bhargava DK; Dasarathy S; Sundaram KR; Ahuja RK
J Gastroenterol Hepatol; 1989; 4 Suppl 1():198-200. PubMed ID: 2519051
[No Abstract] [Full Text] [Related]
39. Selective distal splenorenal shunts for intractable variceal bleeding in pediatric portal hypertension.
Evans S; Stovroff M; Heiss K; Ricketts R
J Pediatr Surg; 1995 Aug; 30(8):1115-8. PubMed ID: 7472961
[TBL] [Abstract][Full Text] [Related]
40. Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension.
Debray D; Lykavieris P; Gauthier F; Dousset B; Sardet A; Munck A; Laselve H; Bernard O
J Hepatol; 1999 Jul; 31(1):77-83. PubMed ID: 10424286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
